Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 1/2008

01-01-2008 | Special Article

Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)

Authors: Masafumi Kurosumi, Sadako Akashi-Tanaka, Futoshi Akiyama, Yoshifumi Komoike, Hirofumi Mukai, Seigo Nakamura, Hitoshi Tsuda, (Committee for Production of Histopathological Criteria for Assessment of Therapeutic Response of the Japanese Breast Cancer Society)

Published in: Breast Cancer | Issue 1/2008

Login to get access

Excerpt

In preoperative drug therapy (chemo-, endocrine, molecular-targeting, and other therapies) and/or radiotherapy for breast cancer, various degrees of histological changes of cancer tissue occur depending on the sensitivity of cancer cells to the particular treatment, kinds of therapeutic agents, dosage of drugs, method of administration, kind of combination, type and dosage of isotope, method of irradiation, duration of treatment, interval from the last treatment, and resection of cancer tissue. Histopathological criteria for assessment of response to neoadjuvant therapy for breast cancer have been established according to the degree of histological change of cancer tissue as described below. …
Literature
1.
Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672–85.PubMed
Metadata
Title
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
Authors
Masafumi Kurosumi
Sadako Akashi-Tanaka
Futoshi Akiyama
Yoshifumi Komoike
Hirofumi Mukai
Seigo Nakamura
Hitoshi Tsuda
(Committee for Production of Histopathological Criteria for Assessment of Therapeutic Response of the Japanese Breast Cancer Society)
Publication date
01-01-2008
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2008
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-007-0016-x

Other articles of this Issue 1/2008

Breast Cancer 1/2008 Go to the issue

Conference Paper

To overcome breast cancer with all of our knowledge

Special Feature: Original Article

Feasibility of accelerated partial breast irradiation using three-dimensional conformal radiation therapy for Japanese women: a theoretical plan using six patients’ CT data

Conference Paper

Considerations in treatment choice for metastatic breast cancer

Conference Paper

Trastuzumab monotherapy versus combination therapy for treating recurrent breast cancer: time to progression and survival

Announcement

Online First publication

Conference Paper

Aromatase inhibitors: from bench to bedside and back
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits